Literature DB >> 19424212

Open innovation networks between academia and industry: an imperative for breakthrough therapies.

Teri Melese1, Salima M Lin, Julia L Chang, Neal H Cohen.   

Abstract

Mesh:

Year:  2009        PMID: 19424212     DOI: 10.1038/nm0509-502

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Translational and clinical science--time for a new vision.

Authors:  Elias A Zerhouni
Journal:  N Engl J Med       Date:  2005-10-12       Impact factor: 91.245

2.  Regulating academic-industrial research relationships--solving problems or stifling progress?

Authors:  Thomas P Stossel
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

3.  Drug discovery alliances.

Authors:  Andrew Jones; Les Clifford
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

4.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

5.  Science careers. Carving a career in translational research.

Authors:  Siri Carpenter
Journal:  Science       Date:  2007-08-17       Impact factor: 47.728

6.  Closing the evidence gap in the use of emerging testing technologies in clinical practice.

Authors:  Kathryn A Phillips
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

7.  Pharma pursues novel models for academic collaboration.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2008-08       Impact factor: 84.694

8.  Science and commerce. Science by the masses.

Authors:  John Travis
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

Review 9.  Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed.

Authors:  Andrew P White; Alexander R Vaccaro; Thomas Zdeblick
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-15       Impact factor: 3.468

10.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

View more
  18 in total

1.  Drug Discovery in Academia- the third way?

Authors:  Julie Frearson; Paul Wyatt
Journal:  Expert Opin Drug Discov       Date:  2010-10-01       Impact factor: 6.098

2.  Public-private partnerships need honest brokering.

Authors:  Michel Goldman
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

3.  Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.

Authors:  Katherine A Rauen; Anuradha Banerjee; W Robert Bishop; Jennifer O Lauchle; Frank McCormick; Martin McMahon; Teri Melese; Pamela N Munster; Sorena Nadaf; Roger J Packer; Judith Sebolt-Leopold; David H Viskochil
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-14       Impact factor: 3.908

Review 4.  The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group.

Authors:  Susanna Wu-Pong; Jogarao Gobburu; Stephen O'Barr; Kumar Shah; Jason Huber; Daniel Weiner
Journal:  Am J Pharm Educ       Date:  2013-05-13       Impact factor: 2.047

5.  In the land of the monolingual.

Authors: 
Journal:  Nat Med       Date:  2009-09       Impact factor: 53.440

Review 6.  Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.

Authors:  Maria Angeles Martinez-Grau; Maria Alvim-Gaston
Journal:  Pharmaceut Med       Date:  2019-06

7.  "It depends:" a qualitative study on digital health academic-industry collaboration.

Authors:  Kelsey L Ford; Jenn Leiferman; Bruno Sobral; John K Bennett; Susan L Moore; Sheana Bull
Journal:  Mhealth       Date:  2021-10-20

Review 8.  The most transformative drugs of the past 25 years: a survey of physicians.

Authors:  Aaron S Kesselheim; Jerry Avorn
Journal:  Nat Rev Drug Discov       Date:  2013-05-17       Impact factor: 84.694

Review 9.  Innovation in biological microscopy: current status and future directions.

Authors:  Jason R Swedlow
Journal:  Bioessays       Date:  2012-03-12       Impact factor: 4.345

Review 10.  The RA-MAP Consortium: a working model for academia-industry collaboration.

Authors:  Andrew P Cope; Michael R Barnes; Alexandra Belson; Michael Binks; Sarah Brockbank; Francisco Bonachela-Capdevila; Claudio Carini; Benjamin A Fisher; Carl S Goodyear; Paul Emery; Michael R Ehrenstein; Neil Gozzard; Ray Harris; Sally Hollis; Sarah Keidel; Marc Levesque; Catharina Lindholm; Michael F McDermott; Iain B McInnes; Christopher M Mela; Gerry Parker; Simon Read; Ayako Wakatsuki Pedersen; Frederique Ponchel; Duncan Porter; Ravi Rao; Anthony Rowe; Peter Schulz-Knappe; Matthew A Sleeman; Deborah Symmons; Peter C Taylor; Brian Tom; Wayne Tsuji; Denny Verbeeck; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2017-12-07       Impact factor: 32.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.